Esperion Therapeutics
ESPR
$1.90
Share price
-4.52%
Change (1 day)
43.94%
Change (1 year)
Categories
Esperion Therapeutics (ESPR) - Total assets
Total assets on the balance sheet as of December 2023 : $0.20 B
According to Esperion Therapeutics's latest financial reports the company's total assets are $0.20 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.20 B | -17% |
| 2022-12-31 | $0.24 B | -35.02% |
| 2021-12-31 | $0.38 B | 8.02% |
| 2020-12-31 | $0.35 B | 64.73% |
| 2019-12-31 | $0.21 B | 49.49% |
| 2018-12-31 | $0.14 B | -48.37% |
| 2017-12-31 | $0.27 B | 13.3% |
| 2016-12-31 | $0.24 B | -17.04% |
| 2015-12-31 | $0.29 B | 106.3% |
| 2014-12-31 | $0.14 B | 83% |
| 2013-12-31 | $78.29 M | 970.7% |
| 2012-12-31 | $7.31 M | 235.47% |
| 2011-12-31 | $2.17 M | |
| 2002-12-31 | $51.4 M | -34.38% |
| 2001-12-31 | $78.34 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 109,960.93% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $33.08 B | 15,974.27% | 🇺🇸 USA |
 Ultragenyx RARE | $1.49 B | 624.51% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.22 B | 11.48% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.77 B | 277.99% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 3,224.46% | 🇺🇸 USA |